Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma

Figure 5

EPC1-related immunoreactive substances (HNSCC samples; TIMER 2.0). Note: (a) EPC1 was positively correlated with M1 (HPV-positive HNSCC samples). (b) EPC1 was positively correlated with IL2 (HPV-positive HNSCC samples). (c) EPC1 was positively correlated with TNFSF15 (HPV-positive HNSCC samples). (d) EPC1 was positively correlated with M2 (HPV-negative HNSCC samples). (e) EPC1 was positively correlated with IL10 (HPV-negative HNSCC samples). (f) EPC1 was positively correlated with MRC1 (HPV-negative HNSCC samples).

(a)

(b)

(c)

(d)

(e)

(f)